The 5th BioPharma Supply Chain and Logistics Nexus takes place on October 22-23, 2024, at the Holiday Inn Piscataway – Somerset Hotel in New Jersey. It is a gathering of professionals and companies/vendors that deal with regulatory affairs, supply chain management, information technology and data analytics, logistics and distribution, compliance, transportation and distribution, procurement and purchasing, packaging and sustainability, warehouse and inventory control, manufacturing and operations, and cold chain management.
The two-day conference features educational presentations, panel discussions and roundtable discussions. Interrupting these sessions are plenty of networking opportunities during extended breaks and planned sessions, allowing attendees to interact with peers, distinguished speakers and…
To learn more, visit https://ibn.fm/klCVo
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
